Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Vanguard Health Care Fund

+ Add to Watchlist

VGHCX:US

230.56 USD 0.91 0.40%

As of 09:29:30 ET on 04/20/2015.

Snapshot for Vanguard Health Care Fund (VGHCX)

Year To Date: +12.00% 3-Month: +8.27% 3-Year: +30.33% 52-Week Range: 170.92 - 233.18
1-Month: -0.75% 1-Year: +37.38% 5-Year: +22.40% Beta vs S5HLTH: 0.91

Mutual Fund Chart for VGHCX

No chart data available.
  • VGHCX:US 230.56
  • 1M
  • 1Y
Interactive VGHCX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for VGHCX

Vanguard Health Care Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund invests at least 80% of its assets in the stocks of companies principally engaged in the development, production, or distribution of products and services related to the health care industry.

Inception Date: 05-23-1984 Telephone: 1-610-669-1000
Managers: JEAN MARIE HYNES
Web Site: www.vanguard.com

Fundamentals for VGHCX

NAV (on 2015-04-20) 230.56
Assets (M) (on 2015-03-31) 50,006.83
Fund Leveraged N
Minimum Investment 10,000.00
Minimum Subsequent Investment 100.00

Dividends for VGHCX

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2015-03-26) 0.82
Dividend Yield (ttm) 10.23

Fees & Expenses for VGHCX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.33
Redemption Fee 0.00
12b1 Fee 0.00
Expense Ratio 0.34

Top Fund Holdings for VGHCX

Filing Date: 12/31/2014
Name Position Value % of Total
Bristol-Myers Squibb Co 39,056,361 2,305,496,990 5.166%
Actavis plc 8,795,896 2,264,151,589 5.073%
UnitedHealth Group Inc 20,519,100 2,074,275,819 4.648%
Merck & Co Inc 35,788,048 2,032,403,246 4.554%
AstraZeneca PLC 23,921,677 1,689,609,175 3.786%
Eli Lilly & Co 21,982,700 1,516,586,473 3.398%
McKesson Corp 6,342,800 1,316,638,424 2.950%
Regeneron Pharmaceuticals Inc 2,921,000 1,198,340,250 2.685%
Vertex Pharmaceuticals Inc 9,808,860 1,165,292,568 2.611%
Roche Holding AG 3,662,498 992,325,331 2.223%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil